Logo 1 Logo 2

Clinical Trial Details

Trial ID: L6446
Source ID: NCT01377961
Associated Drug: Randomized Pills Either Containing Combination Of Lycopene And Isoflavones (Dietary Supplements) Or Placebo To Be Taken For 12 Weeks
Title: Effect of Lycopene and Isoflavones on Glucose Metabolism
Acronym:
Status: WITHDRAWN
Study Results: NO
Results:
Conditions: Metabolic Syndrome|Diabetes Mellitus, Non-Insulin-Dependent
Interventions: DRUG: Randomized pills either containing combination of lycopene and isoflavones (dietary supplements) or Placebo to be taken for 12 weeks|OTHER: Screening|OTHER: OGTT|OTHER: Anthropometrics and Blood pressure|OTHER: Screening|OTHER: Blood Drawing
Outcome Measures: Primary: Insulin Resistance, For Arm 1:Assessment of the Changes in the insulin resistance from baseline to 12 weeks., 12 weeks|A1C, For Arm 2:Assessment of the Changes in the A1C from baseline to 12 weeks., 12 weeks | Secondary: For Arm 1 :AUCglucose, For Arm 1: Changes of AUCglucose from baseline to 12 weeks., 12 weeks|For Arm1 and Arm 2: The secondary outcome measure are Plasma Lipids concentrations, For Arm 2: Changes in the Plasma Lipids concentrations,BMI,Plasma lycopene and isoflavones, EPCs count and function, Chlamydia Trachomatis titers in serum from baseline to 12 weeks., 12 weeks|For Arm 1 :AUCglucose,Plasma Lipids concentrations,BMI,Plasma lycopene and isoflavones concentration,EPCs count and function,Chlamydia Trachomatis titers in serum, For Arm 1: Changes of AUCglucose,Plasma Lipids concentrations,BMI,Plasma lycopene and isoflavones,EPCs count and function,Chlamydia Trachomatis titers in serum from baseline to 12 weeks., 12 weeks
Sponsor/Collaborators: Sponsor: The University of Texas Medical Branch, Galveston
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases:
Enrollment: 0
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2010-09
Completion Date: 2015-08
Results First Posted:
Last Update Posted: 2015-06-26
Locations: Internal Medicine, Galveston, Texas, 77550, United States|Stark Diabetes Center Clinic, Galveston, Texas, 77550, United States
URL: https://clinicaltrials.gov/show/NCT01377961